INDBNK stock news
This page provides real-time market news, earnings updates, and company announcements related to Ind Bank Housing Ltd (INDBNK).
All content is aggregated from trusted financial media and market data sources to help investors stay informed about key market movements and corporate developments.
Last updated as of 2026-03-17 07:49 IST
Gain Therapeutics Announces Presentations at AD/PDTM 2026 and Provides U.S. FDA Regulatory Update
Finviz2026-03-12 11:03:49
MBX Biosciences Reports Fourth Quarter and Full-Year 2025 Financial Results and Recent Corporate Highlights
Finviz2026-03-12 12:03:53
Calidi Biotherapeutics Presents its Innovative and Scalable Manufacturing Process for CLD-401 at the 9th Annual Bioprocessing Summit; FDA Feedback Support Company's Approach to Manufacturing
Finviz2026-03-12 12:03:52
Century Therapeutics Reports Full Year 2025 Financial Results and Business Updates
Finviz2026-03-12 12:03:53
Dare Bioscience Participates in Virtual Investor "What This Means" Segment
Finviz2026-03-12 12:03:53
Candel Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate Highlights
Finviz2026-03-12 12:09:10
NeurAxis to Host Fourth Quarter and Full Year 2025 Results and Business Update Call on Thursday, March 19, 2026
Finviz2026-03-12 13:04:04
Curanex Expands Scientific Advisory Board With Two Distinguished Researchers
Finviz2026-03-12 13:34:04
Exelixis (EXEL) Has Fallen 2.8% Since Its Previous Earnings Report: Is a Recovery Possible?
101 finance2026-03-12 16:40:37
Hallador Energy Company Reports Fourth Quarter and Full Year 2025 Financial and Operating Results
Finviz2026-03-12 20:09:50
Xenetic Biosciences, Inc. Reports Full Year 2025 Financial Results
Finviz2026-03-13 12:06:56
NeOnc Technologies Appoints David Choi as Chief Accounting Officer
Finviz2026-03-13 13:03:11
Sana Biotechnology Announces Continued Positive Clinical Results Through 14 Months from Type 1 Diabetes Study of Islet Cell Transplantation Without Immunosuppression
Finviz2026-03-13 13:03:11
Sana Biotechnology Announces Continued Positive Clinical Results Through 14 Months from Type 1 Diabetes Study of Islet Cell Transplantation Without Immunosuppression
Finviz2026-03-13 13:03:11
Sana Biotechnology Announces Continued Positive Clinical Results Through 14 Months from Type 1 Diabetes Study of Islet Cell Transplantation Without Immunosuppression
Finviz2026-03-13 13:03:11
Akari Therapeutics Releases CEO Corner Highlighting Strategic Progress and Path to Clinical Development Under CEO Abizer Gaslightwala
Finviz2026-03-13 13:19:02
Acumen Pharmaceuticals Announces $35.75 Million Private Placement to Advance Potential Best-in-Class Molecules from Amyloid Beta Oligomer-Selective Enhanced Brain Delivery Portfolio
Finviz2026-03-16 10:33:49
Olema Oncology Reports Fourth Quarter and Full Year 2025 Financial and Operating Results
Finviz2026-03-16 11:03:46
Zenas BioPharma Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
Finviz2026-03-16 11:03:45
HCW Biologics Announces Positive Research Results for CAR-T Cell Therapy Manufactured Utilizing Its Commercial-Ready Proprietary Compound, HCW9206, Published in Science Advances
Finviz2026-03-16 12:03:48
Perspective Therapeutics Provides Recent Business Highlights and Reports Full Year 2025 Results
Finviz2026-03-16 20:12:46
Cue Biopharma Reports Fourth Quarter and Full Year 2025 Financial Results and Business Highlights
Finviz2026-03-16 20:09:45
iBio to Provide an Update on Cardiopulmonary Program Targeting Pulmonary Hypertension Associated with Heart Failure with Preserved Ejection Fraction (PH-HFpEF)
Finviz2026-03-16 20:33:54
Kyntra Bio (KYNB) Fourth Quarter 2025 Earnings Conference Call Transcript
101 finance2026-03-16 22:15:47
Dare Bioscience Participates in Virtual Investor "What This Means" Segment
Finviz2026-03-12 12:03:53
Candel Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate Highlights
Finviz2026-03-12 12:09:10
NeurAxis to Host Fourth Quarter and Full Year 2025 Results and Business Update Call on Thursday, March 19, 2026
Finviz2026-03-12 13:04:04
Curanex Expands Scientific Advisory Board With Two Distinguished Researchers
Finviz2026-03-12 13:34:04
Exelixis (EXEL) Has Fallen 2.8% Since Its Previous Earnings Report: Is a Recovery Possible?
101 finance2026-03-12 16:40:37
Hallador Energy Company Reports Fourth Quarter and Full Year 2025 Financial and Operating Results
Finviz2026-03-12 20:09:50
Xenetic Biosciences, Inc. Reports Full Year 2025 Financial Results
Finviz2026-03-13 12:06:56
NeOnc Technologies Appoints David Choi as Chief Accounting Officer
Finviz2026-03-13 13:03:11
Sana Biotechnology Announces Continued Positive Clinical Results Through 14 Months from Type 1 Diabetes Study of Islet Cell Transplantation Without Immunosuppression
Finviz2026-03-13 13:03:11
Sana Biotechnology Announces Continued Positive Clinical Results Through 14 Months from Type 1 Diabetes Study of Islet Cell Transplantation Without Immunosuppression
Finviz2026-03-13 13:03:11
Sana Biotechnology Announces Continued Positive Clinical Results Through 14 Months from Type 1 Diabetes Study of Islet Cell Transplantation Without Immunosuppression
Finviz2026-03-13 13:03:11
Akari Therapeutics Releases CEO Corner Highlighting Strategic Progress and Path to Clinical Development Under CEO Abizer Gaslightwala
Finviz2026-03-13 13:19:02
Acumen Pharmaceuticals Announces $35.75 Million Private Placement to Advance Potential Best-in-Class Molecules from Amyloid Beta Oligomer-Selective Enhanced Brain Delivery Portfolio
Finviz2026-03-16 10:33:49
Olema Oncology Reports Fourth Quarter and Full Year 2025 Financial and Operating Results
Finviz2026-03-16 11:03:46
Zenas BioPharma Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
Finviz2026-03-16 11:03:45
HCW Biologics Announces Positive Research Results for CAR-T Cell Therapy Manufactured Utilizing Its Commercial-Ready Proprietary Compound, HCW9206, Published in Science Advances
Finviz2026-03-16 12:03:48
Perspective Therapeutics Provides Recent Business Highlights and Reports Full Year 2025 Results
Finviz2026-03-16 20:12:46
Cue Biopharma Reports Fourth Quarter and Full Year 2025 Financial Results and Business Highlights
Finviz2026-03-16 20:09:45
iBio to Provide an Update on Cardiopulmonary Program Targeting Pulmonary Hypertension Associated with Heart Failure with Preserved Ejection Fraction (PH-HFpEF)
Finviz2026-03-16 20:33:54
Kyntra Bio (KYNB) Fourth Quarter 2025 Earnings Conference Call Transcript
101 finance2026-03-16 22:15:47
INDBNK stock price change
On the last trading day, INDBNK stock closed at 40.46 INR, with a price change of -0.86% for the day.
Trade stock perpsINDBNK stock detailsAbout Bitget
The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
Learn more